Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients.
Francesca BisulliGiulia BruschiLorenzo FerriAnna ScarabelloLisa TaruffiLidia Di VitoBarbara MostacciFederica ProviniGiovanna Calandra-BuonauraPaolo TinuperLaura LicchettaFrancesca BisulliPublished in: Journal of clinical medicine (2024)
Background : Ictal bradycardia (IB) and asystole (IA) represent a rare but potentially harmful feature of epileptic seizures. The aim of this study was to study IB/IA in patients with sleep-related hypermotor epilepsy (SHE). Methods : We retrospectively included cases with video-EEG-confirmed SHE who attended our Institute up to January 2021. We reviewed the ictal polysomnography recordings focusing on ECG and identified cases with IB (R-R interval ≥ 2 s or a ≥10% decrease of baseline heart rate) and IA (R-R interval ≥ 4 s). Results : We included 200 patients (123 males, 61.5%), with a mean age of 42 ± 16 years. Twenty patients (20%) had focal cortical dysplasia (FCD) on brain MRI. Eighteen (out of 104 tested, 17.3%) carried pathogenic variants (mTOR pathway, n = 10, nAchR subunits, n = 4, KCNT1, n = 4). We identified IB/IA in four cases (2%): three had IA (mean 10 s) and one had IB. Three patients had FCD (left fronto-insular region, left amygdala, right mid-temporal gyrus) and two had pathogenic variants in DEPDC5 ; both features were more prevalent in patients with IB/IA than those without ( p = 0.003 and p = 0.037, respectively). Conclusions : We identified IB/IA in 2% of patients with SHE and showed that this subgroup more frequently had FCD on brain MRI and pathogenic variants in genes related to the mTOR pathway.
Keyphrases
- heart rate
- ejection fraction
- newly diagnosed
- prognostic factors
- magnetic resonance imaging
- heart rate variability
- blood pressure
- randomized controlled trial
- physical activity
- copy number
- clinical trial
- cell proliferation
- patient reported outcomes
- gene expression
- computed tomography
- magnetic resonance
- depressive symptoms
- white matter
- transcription factor
- double blind